Adenocarcinoma of the salivary gland? A chemo-sensitive disease.
Identifieur interne : 004030 ( PubMed/Corpus ); précédent : 004029; suivant : 004031Adenocarcinoma of the salivary gland? A chemo-sensitive disease.
Auteurs : J D White ; E J Junor ; J. Mcgarva ; J. Mcmanners ; I S HollandSource :
- Clinical oncology (Royal College of Radiologists (Great Britain)) [ 0936-6555 ] ; 2004.
English descriptors
- KwdEn :
- Adenocarcinoma (drug therapy), Adenocarcinoma (pathology), Adenocarcinoma (surgery), Antineoplastic Combined Chemotherapy Protocols (administration & dosage), Antineoplastic Combined Chemotherapy Protocols (therapeutic use), Cisplatin (administration & dosage), Epirubicin (administration & dosage), Fluorouracil (administration & dosage), Humans, Leeching, Lymphedema (etiology), Lymphedema (therapy), Male, Middle Aged, Palliative Care, Radiotherapy, Adjuvant, Salivary Gland Neoplasms (drug therapy), Salivary Gland Neoplasms (pathology), Salivary Gland Neoplasms (surgery).
- MESH :
- chemical , administration & dosage : Cisplatin, Epirubicin, Fluorouracil.
- administration & dosage : Antineoplastic Combined Chemotherapy Protocols.
- drug therapy : Adenocarcinoma, Salivary Gland Neoplasms.
- etiology : Lymphedema.
- pathology : Adenocarcinoma, Salivary Gland Neoplasms.
- surgery : Adenocarcinoma, Salivary Gland Neoplasms.
- therapeutic use : Antineoplastic Combined Chemotherapy Protocols.
- therapy : Lymphedema.
- Humans, Leeching, Male, Middle Aged, Palliative Care, Radiotherapy, Adjuvant.
PubMed: 15074745
Links to Exploration step
pubmed:15074745Le document en format XML
<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en">Adenocarcinoma of the salivary gland? A chemo-sensitive disease.</title>
<author><name sortKey="White, J D" sort="White, J D" uniqKey="White J" first="J D" last="White">J D White</name>
</author>
<author><name sortKey="Junor, E J" sort="Junor, E J" uniqKey="Junor E" first="E J" last="Junor">E J Junor</name>
</author>
<author><name sortKey="Mcgarva, J" sort="Mcgarva, J" uniqKey="Mcgarva J" first="J" last="Mcgarva">J. Mcgarva</name>
</author>
<author><name sortKey="Mcmanners, J" sort="Mcmanners, J" uniqKey="Mcmanners J" first="J" last="Mcmanners">J. Mcmanners</name>
</author>
<author><name sortKey="Holland, I S" sort="Holland, I S" uniqKey="Holland I" first="I S" last="Holland">I S Holland</name>
</author>
</titleStmt>
<publicationStmt><idno type="wicri:source">PubMed</idno>
<date when="2004">2004</date>
<idno type="RBID">pubmed:15074745</idno>
<idno type="pmid">15074745</idno>
<idno type="wicri:Area/PubMed/Corpus">004030</idno>
<idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Corpus" wicri:corpus="PubMed">004030</idno>
</publicationStmt>
<sourceDesc><biblStruct><analytic><title xml:lang="en">Adenocarcinoma of the salivary gland? A chemo-sensitive disease.</title>
<author><name sortKey="White, J D" sort="White, J D" uniqKey="White J" first="J D" last="White">J D White</name>
</author>
<author><name sortKey="Junor, E J" sort="Junor, E J" uniqKey="Junor E" first="E J" last="Junor">E J Junor</name>
</author>
<author><name sortKey="Mcgarva, J" sort="Mcgarva, J" uniqKey="Mcgarva J" first="J" last="Mcgarva">J. Mcgarva</name>
</author>
<author><name sortKey="Mcmanners, J" sort="Mcmanners, J" uniqKey="Mcmanners J" first="J" last="Mcmanners">J. Mcmanners</name>
</author>
<author><name sortKey="Holland, I S" sort="Holland, I S" uniqKey="Holland I" first="I S" last="Holland">I S Holland</name>
</author>
</analytic>
<series><title level="j">Clinical oncology (Royal College of Radiologists (Great Britain))</title>
<idno type="ISSN">0936-6555</idno>
<imprint><date when="2004" type="published">2004</date>
</imprint>
</series>
</biblStruct>
</sourceDesc>
</fileDesc>
<profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>Adenocarcinoma (drug therapy)</term>
<term>Adenocarcinoma (pathology)</term>
<term>Adenocarcinoma (surgery)</term>
<term>Antineoplastic Combined Chemotherapy Protocols (administration & dosage)</term>
<term>Antineoplastic Combined Chemotherapy Protocols (therapeutic use)</term>
<term>Cisplatin (administration & dosage)</term>
<term>Epirubicin (administration & dosage)</term>
<term>Fluorouracil (administration & dosage)</term>
<term>Humans</term>
<term>Leeching</term>
<term>Lymphedema (etiology)</term>
<term>Lymphedema (therapy)</term>
<term>Male</term>
<term>Middle Aged</term>
<term>Palliative Care</term>
<term>Radiotherapy, Adjuvant</term>
<term>Salivary Gland Neoplasms (drug therapy)</term>
<term>Salivary Gland Neoplasms (pathology)</term>
<term>Salivary Gland Neoplasms (surgery)</term>
</keywords>
<keywords scheme="MESH" type="chemical" qualifier="administration & dosage" xml:lang="en"><term>Cisplatin</term>
<term>Epirubicin</term>
<term>Fluorouracil</term>
</keywords>
<keywords scheme="MESH" qualifier="administration & dosage" xml:lang="en"><term>Antineoplastic Combined Chemotherapy Protocols</term>
</keywords>
<keywords scheme="MESH" qualifier="drug therapy" xml:lang="en"><term>Adenocarcinoma</term>
<term>Salivary Gland Neoplasms</term>
</keywords>
<keywords scheme="MESH" qualifier="etiology" xml:lang="en"><term>Lymphedema</term>
</keywords>
<keywords scheme="MESH" qualifier="pathology" xml:lang="en"><term>Adenocarcinoma</term>
<term>Salivary Gland Neoplasms</term>
</keywords>
<keywords scheme="MESH" qualifier="surgery" xml:lang="en"><term>Adenocarcinoma</term>
<term>Salivary Gland Neoplasms</term>
</keywords>
<keywords scheme="MESH" qualifier="therapeutic use" xml:lang="en"><term>Antineoplastic Combined Chemotherapy Protocols</term>
</keywords>
<keywords scheme="MESH" qualifier="therapy" xml:lang="en"><term>Lymphedema</term>
</keywords>
<keywords scheme="MESH" xml:lang="en"><term>Humans</term>
<term>Leeching</term>
<term>Male</term>
<term>Middle Aged</term>
<term>Palliative Care</term>
<term>Radiotherapy, Adjuvant</term>
</keywords>
</textClass>
</profileDesc>
</teiHeader>
</TEI>
<pubmed><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">15074745</PMID>
<DateCreated><Year>2004</Year>
<Month>04</Month>
<Day>12</Day>
</DateCreated>
<DateCompleted><Year>2004</Year>
<Month>06</Month>
<Day>15</Day>
</DateCompleted>
<DateRevised><Year>2013</Year>
<Month>11</Month>
<Day>21</Day>
</DateRevised>
<Article PubModel="Print"><Journal><ISSN IssnType="Print">0936-6555</ISSN>
<JournalIssue CitedMedium="Print"><Volume>16</Volume>
<Issue>2</Issue>
<PubDate><Year>2004</Year>
<Month>Apr</Month>
</PubDate>
</JournalIssue>
<Title>Clinical oncology (Royal College of Radiologists (Great Britain))</Title>
<ISOAbbreviation>Clin Oncol (R Coll Radiol)</ISOAbbreviation>
</Journal>
<ArticleTitle>Adenocarcinoma of the salivary gland? A chemo-sensitive disease.</ArticleTitle>
<Pagination><MedlinePgn>159-60</MedlinePgn>
</Pagination>
<AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>White</LastName>
<ForeName>J D</ForeName>
<Initials>JD</Initials>
</Author>
<Author ValidYN="Y"><LastName>Junor</LastName>
<ForeName>E J</ForeName>
<Initials>EJ</Initials>
</Author>
<Author ValidYN="Y"><LastName>McGarva</LastName>
<ForeName>J</ForeName>
<Initials>J</Initials>
</Author>
<Author ValidYN="Y"><LastName>McManners</LastName>
<ForeName>J</ForeName>
<Initials>J</Initials>
</Author>
<Author ValidYN="Y"><LastName>Holland</LastName>
<ForeName>I S</ForeName>
<Initials>IS</Initials>
</Author>
</AuthorList>
<Language>eng</Language>
<PublicationTypeList><PublicationType UI="D002363">Case Reports</PublicationType>
<PublicationType UI="D016422">Letter</PublicationType>
</PublicationTypeList>
</Article>
<MedlineJournalInfo><Country>England</Country>
<MedlineTA>Clin Oncol (R Coll Radiol)</MedlineTA>
<NlmUniqueID>9002902</NlmUniqueID>
<ISSNLinking>0936-6555</ISSNLinking>
</MedlineJournalInfo>
<ChemicalList><Chemical><RegistryNumber>3Z8479ZZ5X</RegistryNumber>
<NameOfSubstance UI="D015251">Epirubicin</NameOfSubstance>
</Chemical>
<Chemical><RegistryNumber>Q20Q21Q62J</RegistryNumber>
<NameOfSubstance UI="D002945">Cisplatin</NameOfSubstance>
</Chemical>
<Chemical><RegistryNumber>U3P01618RT</RegistryNumber>
<NameOfSubstance UI="D005472">Fluorouracil</NameOfSubstance>
</Chemical>
</ChemicalList>
<SupplMeshList><SupplMeshName Type="Protocol" UI="C080222">FPEPIR regimen</SupplMeshName>
</SupplMeshList>
<CitationSubset>IM</CitationSubset>
<MeshHeadingList><MeshHeading><DescriptorName UI="D000230" MajorTopicYN="N">Adenocarcinoma</DescriptorName>
<QualifierName UI="Q000188" MajorTopicYN="Y">drug therapy</QualifierName>
<QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName>
<QualifierName UI="Q000601" MajorTopicYN="N">surgery</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D000971" MajorTopicYN="N">Antineoplastic Combined Chemotherapy Protocols</DescriptorName>
<QualifierName UI="Q000008" MajorTopicYN="N">administration & dosage</QualifierName>
<QualifierName UI="Q000627" MajorTopicYN="Y">therapeutic use</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D002945" MajorTopicYN="N">Cisplatin</DescriptorName>
<QualifierName UI="Q000008" MajorTopicYN="N">administration & dosage</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D015251" MajorTopicYN="N">Epirubicin</DescriptorName>
<QualifierName UI="Q000008" MajorTopicYN="N">administration & dosage</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D005472" MajorTopicYN="N">Fluorouracil</DescriptorName>
<QualifierName UI="Q000008" MajorTopicYN="N">administration & dosage</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D024763" MajorTopicYN="Y">Leeching</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D008209" MajorTopicYN="N">Lymphedema</DescriptorName>
<QualifierName UI="Q000209" MajorTopicYN="N">etiology</QualifierName>
<QualifierName UI="Q000628" MajorTopicYN="N">therapy</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D010166" MajorTopicYN="N">Palliative Care</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D018714" MajorTopicYN="N">Radiotherapy, Adjuvant</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D012468" MajorTopicYN="N">Salivary Gland Neoplasms</DescriptorName>
<QualifierName UI="Q000188" MajorTopicYN="Y">drug therapy</QualifierName>
<QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName>
<QualifierName UI="Q000601" MajorTopicYN="N">surgery</QualifierName>
</MeshHeading>
</MeshHeadingList>
</MedlineCitation>
<PubmedData><History><PubMedPubDate PubStatus="pubmed"><Year>2004</Year>
<Month>4</Month>
<Day>13</Day>
<Hour>5</Hour>
<Minute>0</Minute>
</PubMedPubDate>
<PubMedPubDate PubStatus="medline"><Year>2004</Year>
<Month>6</Month>
<Day>16</Day>
<Hour>5</Hour>
<Minute>0</Minute>
</PubMedPubDate>
<PubMedPubDate PubStatus="entrez"><Year>2004</Year>
<Month>4</Month>
<Day>13</Day>
<Hour>5</Hour>
<Minute>0</Minute>
</PubMedPubDate>
</History>
<PublicationStatus>ppublish</PublicationStatus>
<ArticleIdList><ArticleId IdType="pubmed">15074745</ArticleId>
</ArticleIdList>
</PubmedData>
</pubmed>
</record>
Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Wicri/Sante/explor/LymphedemaV1/Data/PubMed/Corpus
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 004030 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/PubMed/Corpus/biblio.hfd -nk 004030 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien |wiki= Wicri/Sante |area= LymphedemaV1 |flux= PubMed |étape= Corpus |type= RBID |clé= pubmed:15074745 |texte= Adenocarcinoma of the salivary gland? A chemo-sensitive disease. }}
Pour générer des pages wiki
HfdIndexSelect -h $EXPLOR_AREA/Data/PubMed/Corpus/RBID.i -Sk "pubmed:15074745" \ | HfdSelect -Kh $EXPLOR_AREA/Data/PubMed/Corpus/biblio.hfd \ | NlmPubMed2Wicri -a LymphedemaV1
This area was generated with Dilib version V0.6.31. |